Orexo AB (ORXOF)
1.44
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Orexo Net Income (Quarterly) : -10.95M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.95M |
| March 31, 2026 | -11.51M |
| December 31, 2025 | -12.29M |
| September 30, 2025 | -3.131M |
| June 30, 2025 | -10.09M |
| March 31, 2025 | -8.488M |
| December 31, 2024 | -10.78M |
| September 30, 2024 | -4.020M |
| June 30, 2024 | -3.358M |
| March 31, 2024 | -0.8561M |
| December 31, 2023 | -1.744M |
| September 30, 2023 | -3.080M |
| June 30, 2023 | -1.195M |
| March 31, 2023 | -6.121M |
| December 31, 2022 | -8.559M |
| September 30, 2022 | -2.512M |
| June 30, 2022 | -3.635M |
| March 31, 2022 | -2.526M |
| December 31, 2021 | -7.436M |
| September 30, 2021 | -6.013M |
| June 30, 2021 | -8.761M |
| March 31, 2021 | -3.749M |
| December 31, 2020 | -5.760M |
| September 30, 2020 | -9.574M |
| June 30, 2020 | -3.358M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.532M |
| December 31, 2019 | 4.045M |
| September 30, 2019 | 11.65M |
| June 30, 2019 | 5.779M |
| March 31, 2019 | 1.537M |
| December 31, 2018 | 5.705M |
| September 30, 2018 | 6.953M |
| June 30, 2018 | 5.771M |
| March 31, 2018 | -3.192M |
| December 31, 2017 | 3.209M |
| September 30, 2017 | 3.465M |
| June 30, 2017 | 0.3524M |
| March 31, 2017 | -3.878M |
| December 31, 2016 | 3.678M |
| September 30, 2016 | 4.225M |
| June 30, 2016 | 0.6088M |
| March 31, 2016 | -4.078M |
| December 31, 2015 | -6.095M |
| September 30, 2015 | -5.432M |
| June 30, 2015 | -10.05M |
| March 31, 2015 | -1.858M |
| December 31, 2014 | 6.944M |
| September 30, 2014 | -5.297M |
| June 30, 2014 | -7.603M |
| March 31, 2014 | -3.264M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Swedencare AB | 2.531M |
| Camurus AB | 25.72M |
| Moberg Pharma AB | -0.3504M |
| Infant Bacterial Therapeutics AB | -2.509M |
| AstraZeneca PLC | 3.076B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.3738M |
| Total Expenses (Quarterly) | 11.32M |
| EPS Diluted (Quarterly) | -0.3052 |
| Enterprise Value | 22.99M |
| Gross Profit Margin (Quarterly) | -137.1% |
| Profit Margin (Quarterly) | -2.93K% |
| Earnings Yield | -65.84% |
| Normalized Earnings Yield | -65.85 |